# Studying the Effects of Sibutramine on Eating Behavior

> **NCT01170364** · PHASE4 · TERMINATED · sponsor: **New York State Psychiatric Institute** · enrollment: 14 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Sibutramine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01170364
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-02
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Terminated due to sibutramine being withdrawn from the market.
- **Last updated:** 2017-08-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01170364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01170364, "Studying the Effects of Sibutramine on Eating Behavior". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT01170364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*